Dana-Farber Cancer Institute
450 Brookline Ave,
Boston, 02215, MA,
United States
Boston, 02215, MA,
United States
1 617-632-3000
Healthcare
Dana-Farber Cancer Institute Technographics
Dana-Farber Cancer Institute Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Dana-Farber Cancer Institute and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10000 Dana-Farber Cancer Institute employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Dana-Farber Cancer Institute has purchased the following applications: Appcast Xcelerate for Candidate Relationship Management in 2022, Doximity for Electronic Health Record in 2021, MicroStrategy ONE Analytics for Analytics and BI in 2012 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Dana-Farber Cancer Institute is running and its propensity to invest more and deepen its relationship with Appcast , UKG , Doximity or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Dana-Farber Cancer Institute revenues, which have grown to $2.67 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Dana-Farber Cancer Institute intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Dana-Farber Cancer Institute Tech Stack and Enterprise Applications
Dana-Farber Cancer Institute HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Appcast | Legacy | Appcast Xcelerate | Candidate Relationship Management | HCM | n/a | 2022 | 2022 |
In 2022, Dana-Farber Cancer Institute implemented Appcast Xcelerate. The deployment of Appcast Xcelerate on their website is intended to support Candidate Relationship Management capabilities directly on the public careers experience.
The implementation configures standard Candidate Relationship Management functional modules, including career site job distribution and capture, candidate sourcing and talent pipelining, branded engagement widgets, and automated candidate nurture sequences. Appcast Xcelerate is used to surface and profile inbound applicants, orchestrate candidate touchpoints, and maintain talent pools consistent with CRM workflows.
Deployed on the institution website, the solution is scoped to Talent Acquisition and recruiting teams across Dana-Farber Cancer Institute, routing web-sourced candidate interactions into CRM workflows for ongoing engagement. Operational coverage centers on web-based candidate capture and engagement, with configuration tailored to role-based recruiting processes and outreach cadence.
Governance for Appcast Xcelerate emphasizes centralized recruiting operations for configuration control, data stewardship, and workflow rule management, with phased rollout of site-facing components and recruiter access. Implementation details focus on configuring user roles, campaign templates, and consent-based communication workflows to align Candidate Relationship Management practices with institutional hiring policies.
|
|
|
|
|
Workforce Scheduling | HCM |
|
2022 | 2022 |
|
Dana-Farber Cancer Institute ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Doximity | Legacy | Doximity | Electronic Health Record | ERP Services and Operations | n/a | 2021 | 2021 |
In 2021, Dana-Farber Cancer Institute deployed Doximity Dialer Enterprise as a hospital-wide telehealth solution. The deployment is described within the Electronic Health Record category and supported secure voice and video visits across clinical departments during the COVID-era expansion of virtual care in the United States.
Doximity Dialer Enterprise was configured to operationalize clinical virtual care workflows, enabling secure audio and video encounters, simplifying clinician to patient connections, and supporting care coordination activities. Implementation emphasized capabilities typical of telehealth-enabled EHR adjacent tooling, including session initiation, secure communications, and clinical workflow integration points.
Operational scope covered hospital-wide clinical departments, with the program used by clinical teams to expand access and simplify patient connections across outpatient virtual visit workflows. Governance centered on clinical workflow curation and phased rollout during the pandemic, and the program focused on expanding access and simplifying patient connections, improving care coordination and patient experience as stated.
|
|
|
|
|
Laboratory Management | ERP Services and Operations |
|
2023 | 2023 |
|
|
|
|
|
Lease Management | ERP Services and Operations |
|
2015 | 2015 |
|
Dana-Farber Cancer Institute Analytics and BI
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| MicroStrategy | Legacy | MicroStrategy ONE Analytics | Analytics and BI | Analytics and BI | n/a | 2012 | 2018 |
In 2012, Dana-Farber Cancer Institute implemented MicroStrategy ONE Analytics in the Analytics and BI category to support clinical business operations and planning. The implementation was executed under the Director of Clinical Business Operations, producing deliverables that supported daily operational needs and long term planning with a particular focus on clinical business, scheduling, and infusion workflows.
MicroStrategy ONE Analytics was used as the primary reporting layer, with expert users employing both the web and desktop versions for ad hoc and long term operational reporting. Functional capabilities centered on interactive reporting, ad hoc analysis, operational reporting for scheduling and infusion workflows, and dashboard distribution aligned to clinical operations reporting needs.
The deployment consumed discrete connections from information and scheduling systems into an enterprise data mart for reporting, establishing a reporting architecture that centralized clinical scheduling and infusion data for analysis. Governance and operational ownership remained with Clinical Business Operations, with analytics deliverables produced directly to that office to inform day to day scheduling coordination and longer term operational planning.
|
Dana-Farber Cancer Institute Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Audio Video and Web Conferencing | Collaboration |
|
2021 | 2021 |
|
Dana-Farber Cancer Institute Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Web Content Management | Content Management |
|
2021 | 2021 |
|
Dana-Farber Cancer Institute eCommerce
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
eCommerce | eCommerce |
|
2021 | 2021 |
|
Dana-Farber Cancer Institute CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2021 | 2021 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2021 | 2021 |
|
|
|
|
|
Marketing Automation | CRM |
|
2021 | 2021 |
|
Dana-Farber Cancer Institute ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Performance Management | ITSM |
|
2021 | 2021 |
|
Dana-Farber Cancer Institute TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2021 | 2021 |
|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2021 | 2021 |
|
|
|
|
|
Treasury Management | TRM |
|
2016 | 2017 |
|
Dana-Farber Cancer Institute IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Dana-Farber Cancer Institute
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
Director of Analytics | Director | Finance | |
|
|
|
Analytics Manager, Online Marketing | Manager | Marketing | |
|
|
|
Technical Director Analytics Solutions | Director | IT | |
|
|
|
CIO | CXO | Finance | |
|
|
|
Scientific Director of Research Information Technology | Director | IT | |
|
|
|
Senior Vice President for Finance and Chief Financial Officer | CXO | Finance | |
|
|
|
Senior IT Project Manager | Manager | IT | |
|
|
|
Controller | Director | Finance | |
|
|
|
Director, Research Accounting | Director | Finance | |
|
|
|
Vice President Finance | VP | Finance | |
|
|
|
Senior Director, Patient Financial Services | Director | Finance | |
|
|
|
Senior Director of Financial Operations | Director | Finance | |
|
|
|
Buyer - Purchasing and Travel Manager | Manager | Procurement | |
|
Apps Being Evaluated by Dana-Farber Cancer Institute Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Dana-Farber Cancer Institute IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Dana-Farber Cancer Institute digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Dana-Farber Cancer Institute Technographics
Dana-Farber Cancer Institute is a Healthcare organization based in United States,
with around 10000 employees and annual revenues of $2.67 billion.
Dana-Farber Cancer Institute operates a diverse technology stack with applications such as
Appcast Xcelerate, Doximity and MicroStrategy ONE Analytics,
covering areas like Candidate Relationship Management, Electronic Health Record and Analytics and BI.
Dana-Farber Cancer Institute has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Appcast, Doximity and MicroStrategy.
Dana-Farber Cancer Institute recently adopted applications including
L7 LIMS in 2023, Appcast Xcelerate in 2022 and UKG EZCall in 2022,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Dana-Farber Cancer Institute’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Dana-Farber Cancer Institute’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Dana-Farber Cancer Institute technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.